To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

PHA EUROPE, European Pulmonary Hypertension Association


Wilhelmstrasse 19
1120 Vienna


43 1 402 37 25


43 1 409 35 28

Email Address

[email protected]


PHA EUROPE is a European umbrella organization for pulmonary hypertension, a progressive and incurable lung/heart disease. It was founded in 2003 and is registered in Vienna, Austria, as an international non-profit organization. As of 2012, PHA EUROPE membership includes 25 national pulmonary hypertension patient associations from 22 European countries. The primary objective of PHA Europe is to establish cooperation between the members, the European institutions, international organizations and public institutions in order to achieve the best possible standards of care for pulmonary hypertension patients in Europe.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.